Form DEF 14A BIOCRYST PHARMACEUTICALS For: 23 April

This is not a market event; it is a liability surface. The dominant implication is that the publisher is trying to widen legal distance between itself and any use of the displayed data, which usually matters when content is being scraped, mirrored, or embedded into systematic workflows. For desks that ingest web text into models, the bigger risk is not bad news flow but silent data provenance drift: stale or non-real-time inputs can contaminate signals, backtests, and compliance records without leaving an obvious error trace.

The second-order winner is any vendor with contractual exchange-grade data rights and auditability; the losers are low-cost aggregators, retail-facing data portals, and any quant process relying on “free” web prices as a proxy for executable levels. If this type of disclosure becomes more prominent across data providers, expect a small but real migration of budget from ad-supported sources toward licensed feeds, especially in higher-frequency or regulated strategies where timestamp integrity matters more than cost.

The contrarian view is that the market tends to underprice operational risk when the content is generic and tone-neutral. That is exactly when model contamination can be highest: there is no price shock to force human review, so stale or indicative data can flow straight into risk systems. The catalyst is not days or months of price action; it is an internal controls event, and the failure mode is concentrated in any strategy that uses web-scraped market data, crypto quotes, or cross-asset validation without exchange timestamps.